(Nanowerk News) Microfluidics, the exclusive global provider of Microfluidizer® high shear fluid processors used in the production of emulsions, liposomes and other nanostructures, and Particle Sciences, Inc., a leading contract development and manufacturing organization (CDMO) have entered into a strategic alliance to better fulfill customer requirements for complex formulation development while also extending lab support testing services for Pharmaceutical and Biopharmaceutical processing.
Brad Besse, Business Unit Director at Microfluidics, notes “Particle Sciences has been a good partner in the past, making our decision to work more closely with them an easy one. They have shown themselves to be leaders in nanoparticle production; specifically, with our technology. We believe that by working together, both parties can expand their application expertise and support services to better serve our customer needs. In addition to formulation and clinical trial production, Particle Science affords our customers the ability to work with highly potent compounds under cGMP guidelines, in a purpose-built facility.”
Dr. Mark Mitchnick, Particle Sciences’ CEO adds “Particle Sciences is the leading CDMO for nano-based products. We have worked with Microfluidics since before their acquisition by IDEX, and already have several machines installed. We are seeing an increasing need for the highly consistent performance Microfluidizer® technology is able to deliver. This, combined with Particle Sciences’ deep understanding of the technology, and our base capabilities in characterization and sterile production is driving the relationship expansion. We have formulated multiple products with Microfluidizer® technology, recently manufacturing 120L of a sterile emulsion for a client using the equipment, and have several more in the pipeline”.
Microfluidics is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and nanoparticle creation. The innovative Microfluidics Technology Center, located at the Company’s headquarters outside Boston, MA, is staffed by expert engineers with a wide range of nanotechnology and application experience for proof-of-concept and process development support. Microfluidizer® technology enables companies to create tiny particles that achieve big results. To learn more, please visit www.microfluidicscorp.com, email firstname.lastname@example.org, or contact us at (617) 969-5452.
Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. They also have an extensive history in government contracting alongside their customers. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For further details, please visit www.particlesciences.com, email email@example.com, or contact us at (610) 861- 4701.
Source: Microfluidics (press release)
If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
Check out these other trending stories on Nanowerk: